(IBwire.com – May
2, 2012) - The Law Offices of Marc S. Henzel (www.henzellaw.com)
a firm focusing on shareholder litigation, and is investigating claims on
behalf of investors of Gen-Probe
Inc. (Nasdaq: GPRO) concerning the proposed acquisition by Hologic Inc.
According to reports, shareholders
of Gen-Probe will receive $82.75 per share. The transaction, which is expected
to close in the second half of this year, will add about 20 cents per share to
Hologic's earnings in the first fiscal year after the deal closes. The
transaction has a total approximate value of $3.7 billion.
If you own shares of Gen-Probe Inc. (Nasdaq: GPRO) and
would like to learn more about any potential claims or you wish to discuss
these matters and have any questions concerning this announcement or your
rights, please contact Marc S. Henzel (610) 660-8000, email at Mhenzel@Henzellaw.com, or to sign up
online, visit the firms website at www.henzellaw.com.
The Law Offices
of Marc S. Henzel is a national shareholder litigation firm representing
shareholders & investors in various areas of securities laws including but
not limited to; class actions, derivatives, transactional (buyouts/mergers/acquisitions)
and FINRA & NYSE Arbitrations.
advertising. © 2012 Law Offices of Marc S. Henzel. The law firm responsible for this
advertisement is Marc S. Henzel. Prior
results do not guarantee or predict a similar outcome with respect to any
Offices of Marc S. Henzel